Affordable Access

Ophthalmic Complications Related to Chemotherapy in Medically Complex Patients.

Authors
  • Harman, Lynn E1
  • 1 James Haley Veterans Affairs Hospital, Eye Clinic, Tampa, FL 33612, USA. [email protected]
Type
Published Article
Journal
Cancer control : journal of the Moffitt Cancer Center
Publication Date
Apr 01, 2016
Volume
23
Issue
2
Pages
150–156
Identifiers
PMID: 27218792
Source
Medline
Language
English
License
Unknown

Abstract

Systemic cancer therapies cause a variety of ophthalmic complications. Mitigating harmful adverse events involves screening patients at risk for ocular injury and vision loss. A review of the relevant literature on the ophthalmic complications of cancer therapy was used to formulate an approach to screening patients for serious complications presenting at a nonophthalmic specialty center. Rarely, ocular complications of cancer therapy can occur. Establishing a causal association for any given agent is complicated because many treatment-related adverse events result in symptoms and ocular findings indistinguishable from primary eye disorders. Recognizing potentially serious ocular complications of cancer therapy before they result in irreversible injury starts with taking a relevant clinical history and performing a basic eye examination, including assessments of visual acuity and fields. Given the wide range of treatment-related adverse events and the challenges of diagnosis, the screening process plays an important role in expediting referral to an ophthalmologic specialist.

Report this publication

Statistics

Seen <100 times